Invivo Clinical Limited - Accounts to registrar (filleted) - small 18.2

Invivo Clinical Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v18.2.1.62 06187743 Board of Directors 1.4.17 31.3.18 31.3.18 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure061877432017-03-31061877432018-03-31061877432017-04-012018-03-31061877432016-03-31061877432016-04-012017-03-31061877432017-03-3106187743ns15:EnglandWales2017-04-012018-03-3106187743ns14:PoundSterling2017-04-012018-03-3106187743ns10:Director12017-04-012018-03-3106187743ns10:PrivateLimitedCompanyLtd2017-04-012018-03-3106187743ns10:SmallEntities2017-04-012018-03-3106187743ns10:AuditExempt-NoAccountantsReport2017-04-012018-03-3106187743ns10:SmallCompaniesRegimeForDirectorsReport2017-04-012018-03-3106187743ns10:SmallCompaniesRegimeForAccounts2017-04-012018-03-3106187743ns10:FullAccounts2017-04-012018-03-3106187743ns10:Director22017-04-012018-03-3106187743ns10:Director32017-04-012018-03-3106187743ns10:Director42017-04-012018-03-3106187743ns10:RegisteredOffice2017-04-012018-03-3106187743ns5:CurrentFinancialInstruments2018-03-3106187743ns5:CurrentFinancialInstruments2017-03-3106187743ns5:Non-currentFinancialInstruments2018-03-3106187743ns5:Non-currentFinancialInstruments2017-03-3106187743ns5:ShareCapital2018-03-3106187743ns5:ShareCapital2017-03-3106187743ns5:RetainedEarningsAccumulatedLosses2018-03-3106187743ns5:RetainedEarningsAccumulatedLosses2017-03-3106187743ns5:LeaseholdImprovements2017-04-012018-03-3106187743ns5:PlantMachinery2017-04-012018-03-3106187743ns5:MotorVehicles2017-04-012018-03-3106187743ns5:LandBuildings2017-03-3106187743ns5:LeaseholdImprovements2017-03-3106187743ns5:PlantMachinery2017-03-3106187743ns5:MotorVehicles2017-03-3106187743ns5:LandBuildings2017-04-012018-03-3106187743ns5:LandBuildings2018-03-3106187743ns5:LeaseholdImprovements2018-03-3106187743ns5:PlantMachinery2018-03-3106187743ns5:MotorVehicles2018-03-3106187743ns5:LandBuildings2017-03-3106187743ns5:LeaseholdImprovements2017-03-3106187743ns5:PlantMachinery2017-03-3106187743ns5:MotorVehicles2017-03-3106187743ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-03-3106187743ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-03-3106187743ns5:Secured2018-03-3106187743ns5:Secured2017-03-31


REGISTERED NUMBER: 06187743 (England and Wales)












Unaudited Financial Statements

for the Year Ended 31 March 2018

for

Invivo Clinical Limited

Invivo Clinical Limited (Registered number: 06187743)






Contents of the Financial Statements
for the Year Ended 31 March 2018




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Invivo Clinical Limited

Company Information
for the Year Ended 31 March 2018







Directors: H Bacchus
E J Panczak
N K Richards





Registered office: Unit 1 The New Warehouse
Libby's Drive
Stroud
Gloucestershire
GL5 1RN





Registered number: 06187743 (England and Wales)





Accountants: Crowthers Chartered Accountants
19 High Street
Pershore
Worcestershire
WR10 1AA

Invivo Clinical Limited (Registered number: 06187743)

Balance Sheet
31 March 2018

2018 2017
Notes £    £    £    £   
FIXED ASSETS
Property, plant and equipment 4 378,639 17,786

CURRENT ASSETS
Inventories 116,285 76,227
Debtors 5 108,388 59,243
Cash at bank and in hand 297,328 238,465
522,001 373,935
CREDITORS
Amounts falling due within one year 6 433,009 254,913
NET CURRENT ASSETS 88,992 119,022
TOTAL ASSETS LESS CURRENT
LIABILITIES

467,631

136,808

CREDITORS
Amounts falling due after more than one
year

7

(187,993

)

-

PROVISIONS FOR LIABILITIES (14,672 ) (3,037 )
NET ASSETS 264,966 133,771

CAPITAL AND RESERVES
Called up share capital 101 100
Retained earnings 264,865 133,671
264,966 133,771

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2018 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end
of each financial year and of its profit or loss for each financial year in accordance with the requirements of
Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to
financial statements, so far as applicable to the company.

Invivo Clinical Limited (Registered number: 06187743)

Balance Sheet - continued
31 March 2018


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors on 8 August 2018 and were signed on its behalf by:





D W Maree - Director


Invivo Clinical Limited (Registered number: 06187743)

Notes to the Financial Statements
for the Year Ended 31 March 2018

1. STATUTORY INFORMATION

Invivo Clinical Limited is a private company, limited by shares , registered in England and Wales. The
company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,
value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 25% on reducing balance
Plant and machinery - 25% on reducing balance
Motor vehicles - 25% on reducing balance

Tangible assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated
impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all
costs of purchase, costs of conversion and other costs incurred in bringing stock to its present location and
condition. Cost is calculated using the first-in, first-out formula. Provision is made for damaged, obsolete and
slow-moving stock where appropriate.

Taxation
Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the
current or past reporting periods. It is measured at the amount expected to be paid or recovered using the tax
rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax represents the future tax consequences of transactions and events recognised in the financial
statements of current and previous periods. It is recognised in respect of all timing differences, with certain
exceptions. Timing differences are differences between taxable profits and total comprehensive income as stated
in the financial statements that arise from the inclusion of income and expense in tax assessments in periods
different from those in which they are recognised in the financial statements. Unrelieved tax losses and other
deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the
reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the
balance sheet date that are expected to apply to the reversal of timing differences. Deferred tax on revalued
non-depreciable tangible fixed assets and investment properties is measured using the rates and allowances that
apply to the sale of the asset.

Invivo Clinical Limited (Registered number: 06187743)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2018

2. ACCOUNTING POLICIES - continued

Foreign currencies
Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary
assets and liabilities denominated in foreign currencies at the balance sheet date are reported at the rates of
exchange prevailing at that date.

Exchange differences are recognised in profit and loss in the period in which they arise.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the
lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

Financial instruments
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial
instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and
are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit
and loss in finance costs or income as appropriate. The company does not currently apply hedge accounting for
interest rate and foreign exchange derivatives.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 12 (2017 - 6 ) .

4. PROPERTY, PLANT AND EQUIPMENT
Improvements
Freehold to Plant and Motor
property property machinery vehicles Totals
£    £    £    £    £   
Cost
At 1 April 2017 - - 32,480 - 32,480
Additions 299,758 21,445 44,975 13,551 379,729
At 31 March 2018 299,758 21,445 77,455 13,551 412,209
Depreciation
At 1 April 2017 - - 14,694 - 14,694
Charge for year - 3,652 12,423 2,801 18,876
At 31 March 2018 - 3,652 27,117 2,801 33,570
Net book value
At 31 March 2018 299,758 17,793 50,338 10,750 378,639
At 31 March 2017 - - 17,786 - 17,786

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Trade debtors 79,168 29,850
Other debtors 29,220 29,393
108,388 59,243

Invivo Clinical Limited (Registered number: 06187743)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2018

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Bank loans and overdrafts 29,494 -
Trade creditors 291,697 173,649
Taxation and social security 44,288 38,283
Other creditors 67,530 42,981
433,009 254,913

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2018 2017
£    £   
Bank loans 187,993 -

Amounts falling due in more than five years:

Repayable by instalments
Mortgage 142,481 -

8. SECURED DEBTS

The following secured debts are included within creditors:

2018 2017
£    £   
Bank loans 217,487 -

Lloyds Bank Plc hold a fixed and floating charge over the Freehold Property and the charge also contains a
negative pledge. Lloyds Bank PLC also hold a fixed and floating charge and negative pledge relating to the
assets of the business for the loan of the business.

9. RELATED PARTY DISCLOSURES

During the year a creditor was written off for £6,145 which was owed to a company of which one of the
Director's is a Director and shareholder.